| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 5 | |
| #2 | Canada | 5 | |
| #3 | EPO (European Patent Office) | 5 | |
| #4 | WIPO (World Intellectual Property Organization) | 4 | |
| #5 | China | 3 | |
| #6 | Philippines | 2 | |
| #7 | United States | 2 | |
| #8 | Israel | 1 | |
| #9 | Japan | 1 | |
| #10 | Republic of Korea | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Foods and drinks | |
| #4 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Peptides | |
| #5 | Enzymes | |
| #6 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Levy John P | 18 |
| #2 | Reed Rebecca A | 18 |
| #3 | Hall Frederick L | 16 |
| #4 | Gordon Erlinda M | 16 |
| #5 | Mcnulty Joseph | 9 |
| #6 | Johnson Robert G Jr | 5 |
| #7 | Johnson Robert G | 4 |
| #8 | Joseph Mcnulty | 2 |
| #9 | Johnson Jr Robert G | 2 |
| Publication | Filing date | Title |
|---|---|---|
| CA2902875A1 | Improved thymidine kinase gene | |
| AU2013251291A1 | Pathotropic targeted gene delivery system for cancer and other disorders | |
| AU2011278931A1 | Targeted nanoparticles for cancer and other disorders | |
| EP2353389A1 | Compositions for treating disorders |